These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3005575)

  • 1. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
    Domagala JM; Hanna LD; Heifetz CL; Hutt MP; Mich TF; Sanchez JP; Solomon M
    J Med Chem; 1986 Mar; 29(3):394-404. PubMed ID: 3005575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of action of quinolones].
    Smith JT
    Infection; 1986; 14 Suppl 1():S3-15. PubMed ID: 2420724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of quinolones against Escherichia coli DNA gyrase.
    Yoshida H; Nakamura M; Bogaki M; Ito H; Kojima T; Hattori H; Nakamura S
    Antimicrob Agents Chemother; 1993 Apr; 37(4):839-45. PubMed ID: 8388200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other quinolone carboxylic acids.
    Zweerink MM; Edison A
    Antimicrob Agents Chemother; 1986 Apr; 29(4):598-601. PubMed ID: 3010848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of active site binding of 4-quinolones and novel flavone gyrase inhibitors to DNA gyrase.
    Hilliard JJ; Krause HM; Bernstein JI; Fernandez JA; Nguyen V; Ohemeng KA; Barrett JF
    Adv Exp Med Biol; 1995; 390():59-69. PubMed ID: 8718602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyclic and tricyclic analogs of quinolones: mechanism of action.
    Georgopapadakou NH; Dix BA; Angehrn P; Wick A; Olson GL
    Antimicrob Agents Chemother; 1987 Apr; 31(4):614-6. PubMed ID: 3037999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.
    Tabary X; Moreau N; Dureuil C; Le Goffic F
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1925-8. PubMed ID: 2830840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.
    Neu HC
    J Antimicrob Chemother; 1985 Jul; 16(1):43-8. PubMed ID: 3862659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials.
    Domagala JM; Heifetz CL; Hutt MP; Mich TF; Nichols JB; Solomon M; Worth DF
    J Med Chem; 1988 May; 31(5):991-1001. PubMed ID: 2834557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
    Sanchez JP; Domagala JM; Hagen SE; Heifetz CL; Hutt MP; Nichols JB; Trehan AK
    J Med Chem; 1988 May; 31(5):983-91. PubMed ID: 3361584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of inhibition of DNA gyrase by ES-1273, a novel DNA gyrase inhibitor.
    Oyamada Y; Yamagishi J; Kihara T; Yoshida H; Wachi M; Ito H
    Microbiol Immunol; 2007; 51(10):977-84. PubMed ID: 17951987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Campylobacter jejuni DNA gyrase as the target of quinolones.
    Changkwanyeun R; Usui M; Kongsoi S; Yokoyama K; Kim H; Suthienkul O; Changkaew K; Nakajima C; Tamura Y; Suzuki Y
    J Infect Chemother; 2015 Aug; 21(8):604-9. PubMed ID: 26096494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New 1,4-dihydro[1,8]naphthyridine derivatives as DNA gyrase inhibitors.
    Gençer HK; Levent S; Acar Çevik U; Özkay Y; Ilgın S
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1162-1168. PubMed ID: 28174104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mode of action of 4-quinolones and possible mechanisms of resistance.
    Smith JT
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():21-9. PubMed ID: 3542946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of differential activities of ofloxacin enantiomers.
    Morrissey I; Hoshino K; Sato K; Yoshida A; Hayakawa I; Bures MG; Shen LL
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1775-84. PubMed ID: 8843280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.
    Domagala JM; Heifetz CL; Mich TF; Nichols JB
    J Med Chem; 1986 Apr; 29(4):445-8. PubMed ID: 3007757
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
    Alagumuthu M; Arumugam S
    Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
    Traub WH
    Chemotherapy; 1984; 30(6):379-86. PubMed ID: 6097410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.